Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00975013 · ClinicalTrials.gov registry record
Bone Loss After Laparoscopic Roux-en-Y Gastric Bypass
A clinical trial of Bone Loss and Bariatric Surgery, sponsored by Gundersen Lutheran Medical Foundation.
- Completed
- Registry status
- 40
- Enrollment target
- 1
- Study location
NCT00975013: Completed study of Bone Loss and Bariatric Surgery, sponsored by Gundersen Lutheran Medical Foundation.
NCT00975013 is a study of Bone Loss and Bariatric Surgery that has completed, run by Gundersen Lutheran Medical Foundation. The registered enrollment target is 40 participants, below the 252-participant average among 16 other Bone Loss trials with a reported enrollment target (84% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00975013, a study of Bone Loss and Bariatric Surgery, has completed, sponsored by Gundersen Lutheran Medical Foundation.
- COMPLETED
- Registry status
- 40 participants
- Enrollment target
- 1
- Study location
Study Summary
The objective of this study is to assess changes bone mineral density and bone metabolism after laparoscopic Roux-en-Y gastric bypass surgery. The investigators hypothesize that weight loss after laparoscopic Roux-en-Y gastric bypass surgery will be associated with increased bone turnover, changes in bone metabolism, and loss of bone mass.
Conditions Studied
Study Locations (1)
Wisconsin
- Gundersen Lutheran Health System - La Crosse
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2007-04 |
| Est. Completion | 2009-12 |
What the finished NCT00975013 record still lists
NCT00975013 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 252-participant average among 16 other Bone Loss trials with a reported enrollment target (84% lower).
The record links to 4 conditions, with Bone Loss appearing as the primary indexed condition, and to 0 interventions.
NCT00975013 reports a single indexed study location in Wisconsin.
Frequently Asked Questions
What is clinical trial NCT00975013 about?
NCT00975013 is a clinical study titled "Bone Loss After Laparoscopic Roux-en-Y Gastric Bypass". The objective of this study is to assess changes bone mineral density and bone metabolism after laparoscopic Roux-en-Y gastric bypass surgery. The investigators hypothesize that weight loss after laparoscopic Roux-en-Y gastric bypass surgery will be associated with increased bone turnover, changes i...
What is the current status of trial NCT00975013?
This trial is currently completed. The enrollment target is 40 participants. The study started on 2007-04. Estimated completion is 2009-12.
What conditions does trial NCT00975013 study?
This clinical trial studies the following conditions: Bone Loss, Bariatric Surgery, Bone Density, Gastric Bypass.
Who is sponsoring clinical trial NCT00975013?
This trial is sponsored by Gundersen Lutheran Medical Foundation, which has 7 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00975013 being conducted?
This trial has 1 study location across Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Bone Loss
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00975013's enrollment target sits among peer trials
40 14th of 16 higher than 3 of 16 other Bone Loss trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Bone Loss trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Bone, Exercise, Alendronate, and Caloric Restriction
RECRUITING · Phase 4
-
Skeletal Effects of Type 1 Diabetes on Low-Trauma Fracture Risk
RECRUITING
-
Bone in CKD Alkali Response (BICARb Pilot Trial)
RECRUITING · Phase 2
-
Ridge Augmentation Using Allograft Particles Hydrated With or Without Recombinant Human Platelet-Derived Growth Factor
RECRUITING · NA
-
Lutein, Zeaxathin, and Fish Oil Supplementation
RECRUITING · NA
-
LF111 or Drospirenone Chew vs Non-hormonal Contraceptive Methods on Bone Mineral Density in Adolescent and Adult Women
RECRUITING · Phase 4
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01306019 · 40 participants · Phase 1
Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)
- NCT01608152 · 40 participants
Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors
- NCT01668082 · 40 participants · NA
An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection
- NCT02015013 · 40 participants · Phase 2
Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia